(Q50736412)

18 March 2018

meta-analysis

0 references

title

The first 1000 dendritic cell vaccinees. (English)

1 reference

18 March 2018

1 reference

Derry Ridgway

1

1 reference

18 March 2018

publication date

1 January 2003

1 reference

18 March 2018

published in

Cancer Investigation

1 reference

18 March 2018

volume

21

1 reference

18 March 2018

page(s)

873-886

1 reference

18 March 2018

issue

6

1 reference

18 March 2018

Active immunization against cancer with dendritic cells: the near future

cites work

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120025091

Induction of antigen-specific cytolytic T cells in situ in human melanoma by immunization with synthetic peptide-pulsed autologous antigen presenting cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120025091

Altered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120025091

Results of a phase I clinical trial of vaccination of glioma patients with fusions of dendritic and glioma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120025091

Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120025091

The AKT kinase is activated in multiple myeloma tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120025091

Idiotype-pulsed dendritic cell vaccination for B-cell lymphoma: clinical and immune responses in 35 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120025091

Phase I study in melanoma patients of a vaccine with peptide-pulsed dendritic cells generated in vitro from CD34(+) hematopoietic progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120025091

Dendritic cell vaccination for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120025091

Phase 1 study in patients with metastatic melanoma of immunization with dendritic cells presenting epitopes derived from the melanoma-associated antigens MART-1 and gp100.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120025091

Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120025091

A comparison of two types of dendritic cell as adjuvants for the induction of melanoma-specific T-cell responses in humans following intranodal injection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120025091

Rapid induction of tumor-specific type 1 T helper cells in metastatic melanoma patients by vaccination with mature, cryopreserved, peptide-loaded monocyte-derived dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120025091

The functional interactions between CD98, beta1-integrins, and CD147 in the induction of U937 homotypic aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120025091

Dendritic cell immunotherapy in a neuroendocrine pancreas carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120025091

Ex vivo ras peptide vaccination in patients with advanced pancreatic cancer: results of a phase I/II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120025091

Induction of cellular immunity in a parathyroid carcinoma treated with tumor lysate-pulsed dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120025091

Dendritic cell-based xenoantigen vaccination for prostate cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120025091

Immunotherapy of hormone-refractory prostate cancer with antigen-loaded dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120025091

Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120025091

Induction of Tumor-Specific Cytotoxic T Lymphocytes in Cancer Patients by Autologous Tumor RNA-Transfected Dendritic Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120025091

Regression of human metastatic renal cell carcinoma after vaccination with tumor cell-dendritic cell hybrids

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120025091

21 January 2018

Identifiers

DOI

10.1081/CNV-120025091

1 reference

18 March 2018

release_sh7xblusw5gvrfoonwlb7d57dy

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/sh7xblusw5gvrfoonwlb7d57dy

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

14735692

1 reference

18 March 2018